The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline; Lilly O.; Novartis
Circulating tumor cells (CTCs) dynamics after CDK4/6i for hormone-receptor positive (HR+) metastatic breast cancer (MBC): A biomarker analysis of the PACE randomized phase II study.
 
Lorenzo Gerratana
No Relationships to Disclose
 
Yue Ren
No Relationships to Disclose
 
Carolina Reduzzi
Research Funding - Menarini Silicon Biosystems
 
Meredith M. Regan
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Debiopharm Group (Inst); Ipsen (Inst); Tersera; Tolmar
Research Funding - AstraZeneca (Inst); Bayer (Inst); bioTheranostics (Inst); Bristol-Myers Squibb (Inst); Debiopharm Group (Inst); Ipsen (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Pierre Fabre (Inst); Roche (Inst); TerSera (Inst)
 
Reshma L. Mahtani
Consulting or Advisory Role - Agendia; Amgen; Daiichi Sankyo/Astra Zeneca; Eisai; Genentech/Roche; Gilead Sciences; Hologic/Biotheranostics; Lilly; Merck; Novartis; Pfizer; Puma Biotechnology; Sanofi; Sermonix Pharmaceuticals; Stemline Therapeutics
Travel, Accommodations, Expenses - Agendia; Amgen; AstraZeneca; bioTheranostics; Daiichi Sankyo/Lilly; Eisai; Genentech/Roche; Lilly; Merck; Novartis; Pfizer; Puma Biotechnology; Sanofi; Seagen
 
Cynthia X. Ma
Honoraria - Guardant Health; PlusOne Health
Consulting or Advisory Role - Agendia; AstraZeneca; Athenex; Bayer; Biovica; Gilead Sciences; Lilly; Novartis; Olaris; Pfizer; Sanofi; Seagen; Tempus
Research Funding - Pfizer (Inst); Puma Biotechnology (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate: Authorship - served as a co-author on the subject of endocrine therapy for metastatic breast cancer and receive compensation as an author, less than a few hundred dollars a year. It does not affect my patient care or research.
Travel, Accommodations, Expenses - SABCS; Total Health Conferencing
 
Angela DeMichele
Consulting or Advisory Role - Pfizer (I)
Research Funding - Calithera Biosciences (Inst); Genentech (Inst); Inivata/NeoGenomics (Inst); Novartis (Inst); Pfizer (Inst)
 
Jane Lowe Meisel
Honoraria - Medscape; Total Health Conferencing
Consulting or Advisory Role - AstraZeneca; Curio Science; Genentech; GlaxoSmithKline; Novartis; SeaGen
Research Funding - Pfizer; Seagen
Travel, Accommodations, Expenses - Pfizer; Puma Biotechnology; Total Health Conferencing
 
Kathy Miller
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb/Celgene; Celcuity; Genentech/Roche; Merck
Research Funding - alphamab (Inst); Astex Pharmaceuticals (Inst); British Biotech (Inst); CytomX Therapeutics (Inst); Pfizer (Inst)
 
Trevor Augustus Jolly
No Relationships to Disclose
 
Elizabeth Carloss Riley
No Relationships to Disclose
 
Rubina Qamar
No Relationships to Disclose
 
Priyanka Sharma
Stock and Other Ownership Interests - Amgen Astellas BioPharma (I)
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; GlaxoSmithKline; Merck; Novartis; Pfizer; Sanofi
Research Funding - Bristol-Myers Squibb (Inst); Gilead Sciences; Merck (Inst); Novartis; Novartis (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate
 
Sonya A. Reid
Honoraria - Novartis
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca
Research Funding - Agendia
 
Naomi Yu Ko
Honoraria - Pfizer
Consulting or Advisory Role - Pfizer
Research Funding - Pfizer
Expert Testimony - Williams and Connolly
 
Yuan Liu
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Harold J. Burstein
No Relationships to Disclose
 
Sara M. Tolaney
Consulting or Advisory Role - 4D Pharma; AstraZeneca; Athenex; BeyondSpring Pharmaceuticals; Blueprint Medicines; Bristol-Myers Squibb; Certara Inc; Chugai Pharma; CytomX Therapeutics; Daiichi Sankyo; Eisai; Ellipses Pharma; G1 Therapeutics; Genentech; Immunomedics/Gilead; Infinity Pharmaceuticals; Kyowa Hakko Kirin; Lilly; Merck; Mersana; NanoString Technologies; Nektar; Novartis; Odonate Therapeutics; OncoPep; OncoSec; OncXerna Therapeutics; Paxman; Pfizer; Puma Biotechnology; Reveal Genomics; Samsung Bioepis; Sanofi; Seagen; Zentalis; Zymeworks
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Cyclacel (Inst); Eisai (Inst); Exelixis (Inst); Genentech/Roche (Inst); Immunomedics (Inst); Lilly (Inst); Merck (Inst); NanoString Technologies (Inst); Nektar (Inst); Novartis (Inst); Odonate Therapeutics (Inst); Pfizer (Inst); Sanofi (Inst); Seagen (Inst)
 
Massimo Cristofanilli
Honoraria - Pfizer
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Celcuity; Lilly; Menarini; Olaris; Sermonix Pharmaceuticals; Syantra
Research Funding - Angle; AstraZeneca; Lilly; Menarini Silicon Biosystems; Merck
 
Erica L. Mayer
Consulting or Advisory Role - AstraZeneca; Diaccurate; Gilead Sciences; Lilly; Novartis